/ /

Christine Blank, Contributing Editor
First drug for rare skin cancer wins approval
FDA approved the first treatment for metastatic Merkel cell carcinoma (MCC), a rare, aggressive skin cancer.
CVS Generic Drugs Suit Fails to Get Class Action
California judge blocks 11 classes in suit that claims CVS charged insurers and insured patients more than uninsured patients.
FDA Approves 800 Generics in 2016, but Legislators Think Process Should Be Faster
FDA set a record for generics approval, but is the process still too cumbersome?
Gottlieb FDA nomination praised
Pharmaceutical manufacturers and some consumer groups praised President Donald Trump’s nomination of Dr. Scott Gottlieb as the new FDA commissioner.
Generic versions of major depression drug available
Mylan received approval from FDA to market its desvenlafaxine extended-release tablets, the generic version of Pristiq (Pfizer), for major depressive disorder. Plus, 2 other manufacturers recently received approval for their generic versions of Pristiq.
Once-daily diabetes drug approved
FDA approved 10 mg dapagliflozin and 5 mg saxagliptin (Qtern, AstraZeneca), to treat type 2 diabetes.
Drug approved for nighttime urination, plus two more
FDA recently approved three novel drugs: one to treat frequent urination at night, one to treat carcinoid syndrome diarrhea in cancer patients, and one for dust mite allergies. Here are the details on the three new treatments.

Poll

View Results